Dual Suppression of Oxidative Stress and JAK/STAT3 Signaling Attenuates Inflammation‐Driven Corneal Neovascularization
Advanced Science · 10.11.2026
DOI: 10.1002/advs.78647 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 10.11.2026. Verfasst von Qinghua Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Eye Institute of Shandong First Medical University, Qingd…. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Major Basic research project of Natural Science Foundation of Shandong Province, Taishan Scholar Program.
Abstract (Originalsprache)
Corneal neovascularization (CoNV) is a vision‐threatening disorder driven by persistent oxidative stress and inflammation, yet effective therapies targeting these interconnected pathological processes remain limited. Here, we identify enhanced signal transducer and activator of transcription 3 (STAT3) phosphorylation and inflammatory signaling in corneal samples from patients with CoNV, as well as reactive oxygen species (ROS) accumulation and macrophage infiltration were observed in an alkali burn‐induced mouse model. To address these pathological features, we developed Sta@MSR, a macrophage membrane‐cloaked biomimetic nanozyme integrating ruthenium‐mediated ROS scavenging with Stattic‐mediated STAT3 inhibition. Mechanistically, Sta@MSR attenuated oxidative stress and STAT3‐associated inflammatory signaling, thereby suppressing endothelial angiogenic activity and pathological neovascularization. Furthermore, macrophage membrane cloaking enhanced ocular retention and corneal penetration, facilitating topical delivery. Importantly, Sta@MSR markedly reduced pathological neovascularization and inflammatory injury, restored corneal transparency, and exhibited favorable ocular and systemic biocompatibility. Collectively, this work highlights coordinated regulation of oxidative stress and STAT3 signaling as a promising therapeutic strategy for inflammation‐driven CoNV.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Eye Institute of Shandong First Medical University, Qingdao, China.
- Eye Hospital of Shandong First Medical University (Shandong Eye Hospital), Jinan, China.
- School of Ophthalmology, Shandong First Medical University, Jinan, China.
- State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, China.
ORCID-Profile: Qinghua Li, Yang Li, Wenlong Li, Hua Gao
Förderung
- National Natural Science Foundation of China
- Major Basic research project of Natural Science Foundation of Shandong Province
- Taishan Scholar Program
- Academic Promotion Program of Shandong First Medical University
- Natural Science Foundation of Shandong Province of China
- Shandong Province College Youth Innovation Team Project
- Talent of Lifting engineering for Science and Technology in Shandong
- Open Project of the National Key Laboratory of Structural Chemistry
Zitieren
APA
Li, Q., Li, R., Ren, B., Gong, C., Yan, H., Chen, J., Fu, B., Wei, C., Bao, Q., Li, Y., Liu, X., Li, W., & Gao, H. (2026). Dual Suppression of Oxidative Stress and JAK/STAT3 Signaling Attenuates Inflammation‐Driven Corneal Neovascularization. Advanced Science. https://doi.org/10.1002/advs.78647
Vancouver
Li Q, Li R, Ren B, Gong C, Yan H, Chen J, et al. Dual Suppression of Oxidative Stress and JAK/STAT3 Signaling Attenuates Inflammation‐Driven Corneal Neovascularization. Advanced Science. 2026. doi:10.1002/advs.78647
BibTeX
@article{Li2026,
author = {Li, Qinghua and Li, Ruoxi and Ren, Bingxin and Gong, Chaoya and Yan, Hui and Chen, Jie and Fu, Benzhao and Wei, Chaoqun and Bao, Qingdong and Li, Yang and Liu, Xiaoxue and Li, Wenlong and Gao, Hua},
title = {Dual Suppression of Oxidative Stress and JAK/STAT3 Signaling Attenuates Inflammation‐Driven Corneal Neovascularization},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.78647}
}
EUVIMED